R Baughman

2.0k total citations
60 papers, 1.6k citations indexed

About

R Baughman is a scholar working on Surgery, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, R Baughman has authored 60 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Surgery, 10 papers in Pulmonary and Respiratory Medicine and 9 papers in Molecular Biology. Recurrent topics in R Baughman's work include Inhalation and Respiratory Drug Delivery (10 papers), Heparin-Induced Thrombocytopenia and Thrombosis (8 papers) and Oral and Maxillofacial Pathology (6 papers). R Baughman is often cited by papers focused on Inhalation and Respiratory Drug Delivery (10 papers), Heparin-Induced Thrombocytopenia and Thrombosis (8 papers) and Oral and Maxillofacial Pathology (6 papers). R Baughman collaborates with scholars based in United States, Russia and Canada. R Baughman's co-authors include Andrea Leone‐Bay, Duncan R. Paton, Bryce Weir, Rajesh Agarwal, Michael Grace, H Leipold, Samuel R. Money, W. Charles Sternbergh, James Cassidy and Mark D. Gonze and has published in prestigious journals such as Circulation, The Journal of Immunology and Diabetes Care.

In The Last Decade

R Baughman

60 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
R Baughman United States 27 391 328 271 230 194 60 1.6k
Ornella Bosco Italy 23 167 0.4× 607 1.9× 62 0.2× 141 0.6× 124 0.6× 49 1.6k
Masaki Kawamura Japan 24 393 1.0× 465 1.4× 43 0.2× 283 1.2× 92 0.5× 113 2.0k
Peter A. Simkin United States 28 742 1.9× 399 1.2× 57 0.2× 153 0.7× 74 0.4× 82 2.3k
Thomas M. Saba United States 26 298 0.8× 705 2.1× 27 0.1× 357 1.6× 89 0.5× 77 2.5k
R. G. Mason United States 22 203 0.5× 210 0.6× 18 0.1× 322 1.4× 44 0.2× 84 1.3k
Svetlana Krasnokutsky United States 29 778 2.0× 598 1.8× 17 0.1× 78 0.3× 40 0.2× 64 2.7k
D. E. Hammerschmidt United States 12 256 0.7× 219 0.7× 18 0.1× 299 1.3× 53 0.3× 17 1.6k
Manuel Salzmann Austria 18 175 0.4× 471 1.4× 14 0.1× 194 0.8× 38 0.2× 40 1.6k
Theodore H. Spaet United States 29 457 1.2× 431 1.3× 11 0.0× 452 2.0× 122 0.6× 102 2.7k
Delphine Borgel France 26 320 0.8× 393 1.2× 15 0.1× 99 0.4× 22 0.1× 102 2.1k

Countries citing papers authored by R Baughman

Since Specialization
Citations

This map shows the geographic impact of R Baughman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R Baughman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R Baughman more than expected).

Fields of papers citing papers by R Baughman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by R Baughman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R Baughman. The network helps show where R Baughman may publish in the future.

Co-authorship network of co-authors of R Baughman

This figure shows the co-authorship network connecting the top 25 collaborators of R Baughman. A scholar is included among the top collaborators of R Baughman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R Baughman. R Baughman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Cassidy, James, Stephen D. Luzio, Mark T. Marino, & R Baughman. (2012). Quantification of human serum insulin concentrations in clinical pharmacokinetic or bioequivalence studies: what defines the “best method”?. Clinical Chemistry and Laboratory Medicine (CCLM). 50(4). 663–6. 10 indexed citations
2.
Marino, Mark T., Diane Costello, R Baughman, et al.. (2010). Pharmacokinetics and Pharmacodynamics of Inhaled GLP-1 (MKC253): Proof-of-Concept Studies in Healthy Normal Volunteers and in Patients With Type 2 Diabetes. Clinical Pharmacology & Therapeutics. 88(2). 243–250. 30 indexed citations
3.
Baughman, R, et al.. (2010). Population Pharmacokinetic Model of Human Insulin Following Different Routes of Administration. The Journal of Clinical Pharmacology. 51(7). 1015–1024. 27 indexed citations
4.
Marino, Mark T., James Cassidy, R Baughman, Anders Boss, & Peter Richardson. (2010). A new C‐peptide correction model used to assess bioavailability of regular human insulin. Biopharmaceutics & Drug Disposition. 31(7). 428–435. 2 indexed citations
5.
Amin, Nikhil, et al.. (2010). Insulin pharmacokinetics following dosing with Technosphere insulin in subjects with chronic obstructive pulmonary disease. Current Medical Research and Opinion. 26(10). 2347–2353. 11 indexed citations
6.
Tran, Phan‐Kiet, Charles J. Cunningham, & R Baughman. (2004). Glandular Odontogenic Cyst. Journal of Endodontics. 30(3). 182–184. 26 indexed citations
7.
Lepore, Michael R., Mark D. Gonze, Andrea Leone‐Bay, et al.. (2000). Treatment of Experimentally Induced Caval Thrombosis With Oral Low Molecular Weight Heparin and Delivery Agent in a Porcine Model of Deep Venous Thrombosis. Annals of Surgery. 231(6). 789–794. 27 indexed citations
8.
Gonze, Mark D., et al.. (1999). Oral low–molecular weight heparin and delivery agent prevents jugular venous thrombosis in the rat. Journal of Vascular Surgery. 30(3). 526–532. 30 indexed citations
9.
Gonze, Mark D., Andrea Leone‐Bay, R Baughman, et al.. (1998). Orally administered heparin for preventing deep venous thrombosis. The American Journal of Surgery. 176(2). 176–178. 44 indexed citations
10.
Baughman, R, Shiv Kapoor, Rajesh Agarwal, et al.. (1998). Oral Delivery of Anticoagulant Doses of Heparin. Circulation. 98(16). 1610–1615. 110 indexed citations
11.
Leone‐Bay, Andrea, et al.. (1997). Oral Delivery of Heparin in Combination with Sodium N-[8-(2-Hydroxybenzoyl)amino]caprylate: Pharmacological Considerations. Pharmaceutical Research. 14(12). 1830–1834. 63 indexed citations
12.
Leone‐Bay, Andrea, et al.. (1996). Oral Delivery of Sodium Cromolyn: Preliminary Studies In Vivo and In Vitro. Pharmaceutical Research. 13(2). 222–226. 35 indexed citations
13.
Chaudhary, Kiran, et al.. (1994). Stability Study of Drug-loaded Proteinoid Microsphere Formulations during Freeze-drying. Journal of drug targeting. 2(1). 9–21. 29 indexed citations
14.
Kung, Ada H. C., R Baughman, & James W. Larrick. (1993). Therapeutic proteins : pharmacokinetics and pharmacodynamics. 12 indexed citations
15.
Malfroy, Bernard, Denny Liggitt, James McCabe, et al.. (1990). Administration of recombinant enkephalinase (neutral endopeptidase) prevents capsaicin-induced miosis in the rabbit eye in vivo.. Journal of Pharmacology and Experimental Therapeutics. 252(2). 462–465. 7 indexed citations
16.
Findlay, J. Max, Bryce Weir, Kenji Kanamaru, et al.. (1989). Intrathecal Fibrinolytic Therapy after Subarachnoid Hemorrhage: Dosage Study in a Primate Model and Review of the Literature. Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques. 16(1). 28–40. 45 indexed citations
17.
Findlay, J. Max, Bryce Weir, P. Gordon, Michael Grace, & R Baughman. (1989). Safety and Efficacy of Intrathecal Thrombolytic Therapy in a Primate Model of Cerebral Vasospasm. Neurosurgery. 24(4). 491–498. 54 indexed citations
18.
19.
Nicolau, G., et al.. (1987). Deposition of viprostol (a synthetic PGE2vasodilator) in the skin following topical administration to laboratory animals. Xenobiotica. 17(9). 1113–1120. 13 indexed citations
20.
Mico, Bruce A., R Baughman, & Leslie Z. Benet. (1982). Determination of tiodazosin in plasma and whole blood by high-performance liquid chromatography. Journal of Chromatography B Biomedical Sciences and Applications. 230(1). 203–206. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ornella Bosco Breakdown of academic impact, for papers by Masaki Kawamura Breakdown of academic impact, for papers by Peter A. Simkin Breakdown of academic impact, for papers by Thomas M. Saba Breakdown of academic impact, for papers by R. G. Mason Breakdown of academic impact, for papers by Svetlana Krasnokutsky Breakdown of academic impact, for papers by D. E. Hammerschmidt Breakdown of academic impact, for papers by Manuel Salzmann Breakdown of academic impact, for papers by Theodore H. Spaet Breakdown of academic impact, for papers by Delphine Borgel
Rankless by CCL
2026